(Stroke. 2001;32:1750.)
© 2001 American Heart Association, Inc.
Original Contributions |
Production During Human Ischemic Stroke
From the Department of Clinical Neurosciences, Helsinki University Central Hospital (T.S., M.K., P.J.L.); Department of Pathology, Haartman Institute (T.S., O.C., M.-L.K.-L., A.P.); Laboratory, Helsinki University Central Hospital (U.T.); and Neuroscience Program, Biomedicum (M.K., P.J.L.), Helsinki, Finland.
Reprint requests to Dr Tiina Sairanen, Department of Clinical Neurosciences, Helsinki University Central Hospital, Haartmaninkatu 4, FIN-00290 Helsinki, Finland. E-mail Tiina.sairanen{at}helsinki.fi
Background and Purpose Tumor necrosis factor-
(TNF-
) is detected in ischemic brain cells in experimental animal models and is believed to play an important role in apoptosis. However, the natural expression of TNF-
during human stroke is not known.
Methods We examined TNF-
immunohistochemistry and terminal deoxynucleotidyl transferasemediated dUTP nick-end labeling (TUNEL) in brain samples of stroke victims (n=16) after variable survival (15 hours to 18 days). Systemic TNF-
content from a separate cohort including severe or lethal stroke cases (n=26) was also assayed.
Results Neuronal TNF-
was demonstrated from 0.6 to 5.4 days after the onset of stroke symptoms, peaking bilaterally during days 2 and 3. Bilateral glial TNF-
immunoreactivity was detected during the acute phase, with the astrocytic TNF-
expression dominating in later phases and persisting contralaterally to the infarct in more matured phases (17 to 18 days). Invading inflammatory cells were TNF-
immunopositive beginning on the third day. Besides, vascular wall structures showed immunoreactivity sporadically. TNF-
levels were mostly nondetectable in peripheral blood. TUNEL labeling and TNF-
staining overlapped, although not completely, during the first days.
Conclusions The data support the hypothesis that TNF-
may be involved both in the acute propagation of inflammatory processes and cell death and possibly in the more delayed reconstitutive processes of human ischemic stroke.
Department of Anatomy and Cell Biology, University of Western Ontario, London, Ontario, Canada
This article has been cited by other articles:
![]() |
S. Berger, S. I. Savitz, S. Nijhawan, M. Singh, J. David, P. S. Rosenbaum, and D. M. Rosenbaum Deleterious Role of TNF-{alpha} in Retinal Ischemia-Reperfusion Injury Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3605 - 3610. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Baranova, L. F. Miranda, P. Pichiule, I. Dragatsis, R. S. Johnson, and J. C. Chavez Neuron-Specific Inactivation of the Hypoxia Inducible Factor 1{alpha} Increases Brain Injury in a Mouse Model of Transient Focal Cerebral Ischemia J. Neurosci., June 6, 2007; 27(23): 6320 - 6332. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Iosif, C. T. Ekdahl, H. Ahlenius, C. J. H. Pronk, S. Bonde, Z. Kokaia, S.-E. W. Jacobsen, and O. Lindvall Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J. Neurosci., September 20, 2006; 26(38): 9703 - 9712. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Cheranov and J. H. Jaggar TNF-{alpha} dilates cerebral arteries via NAD(P)H oxidase-dependent Ca2+ spark activation Am J Physiol Cell Physiol, April 1, 2006; 290(4): C964 - C971. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sairanen, M.-L. Karjalainen-Lindsberg, A. Paetau, P. Ijas, and P. J. Lindsberg Apoptosis dominant in the periinfarct area of human ischaemic stroke--a possible target of antiapoptotic treatments Brain, January 1, 2006; 129(1): 189 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Fagan, D. C. Hess, E. J. Hohnadel, D. M. Pollock, and A. Ergul Targets for Vascular Protection After Acute Ischemic Stroke Stroke, September 1, 2004; 35(9): 2220 - 2225. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nurmi, P. J. Lindsberg, M. Koistinaho, W. Zhang, E. Juettler, M.-L. Karjalainen-Lindsberg, F. Weih, N. Frank, M. Schwaninger, and J. Koistinaho Nuclear Factor-{kappa}B Contributes to Infarction After Permanent Focal Ischemia Stroke, April 1, 2004; 35(4): 987 - 991. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Rainer, L. K.S. Wong, W. Lam, E. Yuen, N. Y.L. Lam, C. Metreweli, and Y.M. D. Lo Prognostic Use of Circulating Plasma Nucleic Acid Concentrations in Patients with Acute Stroke Clin. Chem., April 1, 2003; 49(4): 562 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Akassoglou, E. Douni, J. Bauer, H. Lassmann, G. Kollias, and L. Probert Exclusive tumor necrosis factor (TNF) signaling by the p75TNF receptor triggers inflammatory ischemia in the CNS of transgenic mice PNAS, January 21, 2003; 100(2): 709 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Castellanos, J. Castillo, M. M. Garcia, R. Leira, J. Serena, A. Chamorro, and A. Davalos Inflammation-Mediated Damage in Progressing Lacunar Infarctions: A Potential Therapeutic Target Stroke, April 1, 2002; 33(4): 982 - 987. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |